Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
ViroMissile, Inc.
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Essen Biotech
Jonsson Comprehensive Cancer Center
MacroGenics
City of Hope Medical Center
Daiichi Sankyo
Second Life Therapeutics
Ocellaris Pharma, Inc.
OncoNano Medicine, Inc.
Mayo Clinic
Memorial Sloan Kettering Cancer Center
University of Pittsburgh
University Health Network, Toronto
NeoTX Therapeutics Ltd.
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
University of Arizona
Institut Bergonié
Day One Biopharmaceuticals, Inc.
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Cancer Research UK
Toray Industries, Inc
Memorial Sloan Kettering Cancer Center
Marengo Therapeutics, Inc.
Genentech, Inc.
NGM Biopharmaceuticals, Inc
Revolution Medicines, Inc.
Seagen Inc.
Stanford University
Sotio Biotech Inc.
European Organisation for Research and Treatment of Cancer - EORTC
Xencor, Inc.
ADC Therapeutics S.A.
Cedars-Sinai Medical Center
Pfizer
Adaptimmune
Rutgers, The State University of New Jersey
Massachusetts General Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Klus Pharma Inc.
Revolution Medicines, Inc.
Eastern Cooperative Oncology Group
4D pharma plc
Jules Bordet Institute
Bristol-Myers Squibb
Quadriga Biosciences, Inc.